Antagningsdata

Välj region och språk

Välj språk för hela webbplatsen.

Publicerad utbildningskatalog

Biotechnology in Defence and Security: Medical Opportunities and Legal Challenges

Utbildningsinformation från den publicerade källan. Utbildningen och dess tidsbundna tillfällen hålls åtskilda.

Utbildningsfakta

Kod: VMFB44

<p>During the course, we explore how future biotechnology and medical advances can be used in defense and security. We discuss the possibilities and risks of technology, how it can be used to promote humanitarian causes in international conflicts, while also analysing legal and ethical challenges.</p><p>This online course provides an interdisciplinary orientation at the intersections of security policy, biotechnology and medical research. The course has a general approach and is suitable for a wide group of students, whether you are completely new as a student or a PhD student in a related field. </p><p>You will learn which technologies are considered to dominate a future geopolitical power struggle and even help a country win on the battlefield. The course also offers a deep-dive into how international conflicts affect healthcare and medical research, as well as how biomedical engineering has been misused in past conflicts, with examples ranging from disinformation to biological weapons. You will also get an overview of national and international laws and conventions that regulate the borderland between medical research and international conflict.</p><p> </p>

Behörighet

General requirements and studies equivalent to Swedish Upper Secondary School courses English 6/English level 2

Utbildningstillfällen

Varje tillfälle har egna datum och villkor. Avslutade tillfällen behålls som historik och innebär inte att en ny ansökan är öppen.

Källa och uppdatering

Skolverket Susa-navet

Hämtad: .

Publicerad: .

Visa källversion

Publiceringsversion: 8e217193-f5fa-4778-b085-a4521fd03e8d

Kontrollsumma: 1b0dc54c0fc8a359f83ba9dc8f9d468479ce432de4c03bce3b8b33dd67fe3f6c

Senast ändrad enligt källan: 2026-03-25T09:25:43